Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …

Background Non-fatal health outcomes from diseases and injuries are a crucial consideration
in the promotion and monitoring of individual and population health. The Global Burden of …

Background Measuring disease and injury burden in populations requires a composite metric
that captures both premature mortality and the prevalence and severity of ill-health. The …

Background The Global Burden of Disease Study 2013 (GBD 2013) aims to bring together
all available epidemiological data using a coherent measurement framework, standardised …

The publication of the Global Burden of Disease Study 2010 (GBD 2010) and the accompanying
collection of Lancet articles in December 2012 provided the most comprehensive …

Background Dengue is the most common arbovirus infection globally, but its burden is poorly
quantified. We estimated dengue mortality, incidence, and burden for the Global Burden of …

Importance Disability secondary to skin conditions is substantial worldwide. The Global
Burden of Disease Study 2013 includes estimates of global morbidity and mortality due to skin …

The Global Burden of Disease Study (GBD) is a landmark initiative that systematically
quantifies the prevalence, morbidity, and mortality for hundreds of diseases, injuries, and risk …

Background High-quality epidemiological studies evaluating the burden of cutaneous
leishmaniasis worldwide are lacking. We compared the burden of cutaneous leishmaniasis in …

Background The African Programme for Onchocerciasis Control (APOC) was created in
1995 to establish community-directed treatment with ivermectin (CDTi) in order to control …